Mo1835 - Soluble Madcam-1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Inflammatory Bowel Diseases under Vedolizumab: A Proof of Concept

Authors :: Xavier Roblin
Bernard Flourié
Stéphane Paul
Stéphane Nancey
Nicolas Williet
Source :: Gastroenterology. 154:S-819
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Hepatology
medicine.diagnostic_test
biology
business.industry
Gastroenterology
Retinoic acid
Inflammatory Bowel Diseases
Pharmacology
Vedolizumab
chemistry.chemical_compound
chemistry
Therapeutic drug monitoring
Addressin
biology.protein
Medicine
business
medicine.drug

Full Text Access

Tools